Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Controlled, Parallel-group Clinical Investigation Evaluating the Impact of Digital Cognitive Behavioural Therapy on Psychological Symptom Burden in Adults Diagnosed With Pulmonary Fibrosis

NCT05330312 is registered in ClinicalTrials.gov with Vicore Pharma AB as lead sponsor.

NCT NCT05330312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05330312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Controlled, Parallel-group Clinical Investigation Evaluating the Impact of Digital Cognitive Behavioural Therapy on Psychological Symptom Burden in Adults Diagnosed With Pulmonary Fibrosis
Lead sponsor
Vicore Pharma AB
Phase
Not applicable
Overall status
Completed
Start date
April 17, 2022
Completion date
November 10, 2023
Enrollment
119 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, pulmonary fibrosis